Thank you, Mike, and good morning, everyone. Turning to the income statement on Slide 9. We delivered strong year-over-year results this quarter, achieving healthy revenue and adjusted EBITDA growth along with continued margin expansion. As Eric mentioned, we had some challenges in our Industrial Services business, but overall, demand trends for our core business lines continue to be strong. Within SKSS, we were disappointed that the promising Q2 we delivered did not carry over into Q3 as demand began to wane and the typical seasonal strength in summer pricing deteriorated, particularly late in the quarter. On the top line, similar to Q2, we achieved a good mix of organic and acquisition related growth as we grew total revenues by 12% or more than $160 million year-over-year. Adjusted EBITDA of $302 million was up nearly $47 million from a year-ago. Our adjusted EBITDA margin in the quarter was 19.7%, up 100 basis points year-over-year as margin improved in both operating segments. The continued margin expansion reflects the leverage in the business given the higher revenues generated from our disposal network and SK branch, as we again received a record level of drum waste into our facilities as well as the sizable growth in field services that Eric noted. SG&A expense as a percentage of revenue was 11.6% in Q3, which is 90 basis points better than the year-ago period. Combined with our revenue growth, the primary factors behind this improvement on a percentage basis were synergies from acquired businesses and lower incentive compensation. For full-year 2024, we continue to anticipate our SG&A expense as a percentage of revenue to be in the mid-12% range. Depreciation and amortization in Q3 came in as expected at $100 million up from a year-ago due to acquisitions. For 2024, we continue to expect depreciation and amortization in the range of $395 million to $405 million. Income from operations in Q3 was $192.3 million up 25% from the prior year. Q3 net income increased 26% versus the prior year to $115.2 million resulting in an earnings per share of $2.12. Turning to Slide 10 and the balance sheet. Cash and short-term marketable securities at quarter end were $595 million up $100 million from the end of Q2 and $44 million since the year began. Our receivables increased by $28 million in Q3 sequentially from Q2 and after growing $186 million in the first half of the year largely due to acquisitions. We had expected to cut into that balance in Q3 rather than increasing it, but the delayed transition of HEPACO onto our billing system added to our receivables balance. The HEPACO integration onto our billing platform is now complete. However, the transition and associated billing delays will impact the timing and extent of cash flows fiscal year 2024. Another item on our balance sheet I wanted to speak to is our buildup in inventories, particularly as it relates to SKSS. Since the start of the year, overall SKSS oil inventories have increased $31 million with $10 million of the increase occurring in Q3, as demand has softened and volumes sold are less than what was expected. Given this inventory growth and expectations looking forward, we made the decision to idle production at our California re-refinery, as Mike referenced. We expect our inventory balance in this business to be reduced in the quarters ahead as we work off the excess levels currently on hand. We ended Q3 with just under $2.79 billion in debt. The increase you see on the slide since the beginning of the year reflects the $500 million in incremental term loan we issued to finance HEPACO and Noble acquisitions earlier this year. Our balance sheet remains very healthy. Our net debt to EBITDA ratio was 2.1 times at quarter end with no material debt amounts coming due until 2027. We also announced in mid-October that we repriced our term loan, which will result in approximately $2 million in annual interest savings going forward. Our overall interest rate at quarter end was 5.65%. Turning to cash flows on Slide 11. Net cash from operating activities in Q3 was $239 million up 9% from prior year. CapEx, net of disposals was $94.7 million down from prior year and in line with our expectations. That number includes $20 million in Q3 spend on the new Kimbell incinerator to complete its construction for commercial launch. Total year-to-date spend now sits at just over $60 million for Kimbell. For the quarter, adjusted free cash flow was $144.5 million, which was $30 million ahead of prior year, but fell short of our expectations due to working capital impacts related to the unbilled AR and increased inventory levels in SKSS that I mentioned a moment ago. For 2024, we continue to expect our net CapEx to be in the range of $400 million to $430 million. This range includes the spend related to Kimbell and $20 million for the purchase and expansion of the Baltimore facility. During Q3, we bought back 85,000 shares of stock at an average price of $236 a share for a total of $20 million bringing our year-to-date total to $30 million. Moving to Slide 12. Based on our Q3 results and market conditions, we are revising our 2024 adjusted EBITDA guidance to a midpoint of $1.11 billion, which represents a 10% increase from 2023. This guidance assumes approximately $40 million in contributions from HEPACO and approximately $5 million from Noble Oil. We now expect our full-year 2024 adjusted EBITDA guidance to translate to our segments as follows. In Environmental Services, we now expect adjusted EBITDA in 2024 at the midpoint of our guidance to increase 13% to 15% from 2023. Most of our core ES businesses will close out the year strong with healthy volume growth. For SKSS, based on the current market conditions around lubricant and base oil demand corresponding pricing, we are now guiding full-year 2024 adjusted EBITDA to decrease 12% to 14% from 2023 at the midpoint of our guidance. While we have some promising initiatives underway and are taking the actions that Mike highlighted, we expect the softer demand and pricing pressures we experienced in Q3 to continue into the seasonally weaker fourth quarter. Within corporate, at the midpoint of our guide, we expect negative adjusted EBITDA to be up 12% to 13% compared to 2023. The year-over-year increase in corporate primarily relates to costs related to the acquisitions and insurance costs. For 2024, we are lowering our adjusted free cash flow expectations for the year based primarily on two factors: the higher inventories we are carrying in our SKSS business and delayed timing of AR cash generation stemming from the integration of HEPACO into our billing system. In both instances, we are confident that these impacts are temporary and just a matter of timing. We estimate the impact of these issues in this year's cash flows to be worth approximately $70 million and as a result, we are lowering our 2024 free cash flow range to $280 million to $320 million or a midpoint of $300 million. In closing, the ES segment continues to experience positive market dynamics that drive waste into our network, and we are on the cusp of Kimbell coming online. Our SK Branch business is performing well as is our field services business with the addition of HEPACO. While the fall turnaround season is limiting the growth in industrial services to close out this year. We believe we are well positioned in that business as the industry leader for SKSS. We remain focused on stabilizing that business after another challenging year and having the right long-term strategy in place. Overall, 2024 will be a year of strong, profitable growth and we are optimistic about our prospects for continued growth into 2025. And with that, Christine, please open the call up for questions.